(1)
Farahani, P. NON-SEVERE HYPOGLYCEMIA RISK DIFFERENCE BETWEEN SULFONYLUREA AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2-I) AS AN ADD-ON TO METFORMIN IN RANDOMIZED CONTROLLED TRIALS. J Popl Ther Clin Pharmacol 2017, 24 (2), e32-e40. https://doi.org/10.22374/1710-6222.24.2.6.